AtriCure Inc (NASDAQ: ATRC) has reported E.P.S. of $-0.28 for its first fiscal quarter (ending March 31) versus $-0.14 for the same period a year ago. Relative to the consensus estimate of $-0.20, this was a shortfall of $-0.08. For the latest four quarters through March 31, E.P.S. were $-0.80 compared to $-0.82 a year ago.
Recent Price Action
AtriCure Inc (NASDAQ: ATRC) stock closed at $24.76 on 5/1/24 after a large increase of 2.7%. Moreover, trading volume in this advance was unusually high at 180% of normal. The stock has risen 6.9% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ATRC is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
AtriCure has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. AtriCure has a very low Appreciation Score of 13 and a very low Power Rating of 2, leading to the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment